Mayne Pharma | Bruttoergebnis Vom Umsatz



Gross Profit On Sales Veränderung Datum
Ansell USD 326.2M 27.6M 2024-06
Avita Medical AUD 16.13M 3.05M 2024-12
Cochlear AUD 867.2M 38.9M 2024-06
CSL USD 3.34B 991M 2024-06
Ecofibre AUD 2.08M 4.33M 2024-06
Healius AUD 554.4M 415.55M 2024-12
Integral Diagnostics AUD 226.91M 7.04M 2024-06
Medical Developments International AUD 13.36M 2.36M 2024-06
Nanosonics AUD 34.5M 28.94M 2024-06
Next Science USD 8.97M 440.45K 2024-06
Polynovo AUD 23.26M 22.74M 2024-06
Ramsay Health Care AUD 6.32B 20.5M 2024-12
ResMed USD 751.28M 34.06M 2024-12
Sigma Healthcare AUD 160.13M 10.55M 2024-07
Sonic Healthcare AUD 3.92B 3.14B 2024-12
Telix Pharmaceuticals AUD 225.7M 52.36M 2024-06



Mayne Pharma Bruttoergebnis Vom Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.